Expression of the hepatic endothelin system in human cirrhotic livers

Journal of Pathology

Volumn 204, Issue 3, 2004, Pages 304-310

  Ikura, Yoshihiro ^a   Ohsawa, Masahiko ^a   Naruko, Takahiko ^b   Muraguchi, Takashi ^a   Hirayama, Michihiko ^a   Suekane, Takehisa ^a   Fukushima, Hiroko ^a   Sugama, Yoshimi ^a   Shirai, Nobuyuki ^a   Kayo, Soichiro ^a   Yoshimi, Noriko ^a   Ehara, Shoichi ^a   Tanzawa, Kazuhiko ^c   Ueda, Makiko ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY GENERAL HOSPITAL   (Japan)

^c DAIICHI SANKYO CO   (Japan)

Author keywords

Endothelin receptor; Endothelin 1; Endothelin converting enzyme; Liver cirrhosis; Portal hypertension

Indexed keywords

ENDOTHELIN; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN RECEPTOR; LIVER PROTEIN; MESSENGER RNA; PEPTIDE; RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER BLOOD FLOW; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; PATHOGENESIS; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; RNA EXTRACTION; STATISTICAL SIGNIFICANCE; UPREGULATION;

AGED; ASPARTIC ENDOPEPTIDASES; BLOTTING, WESTERN; ENDOTHELIN-1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; MALE; METALLOENDOPEPTIDASES; POLYMERASE CHAIN REACTION; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX;

EID: 7244231215     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1644     Document Type: Article

References (26)

1. Moller S, Henriksen JH. Endothelins in chronic liver disease. Scand J Clin Lab Invest 1996; 56: 481-490.
2. Mallat A, Lotersztajn S. Multiple hepatic functions of endothelin-1: physiopathological relevance. J Hepatol 1996; 25 405-413.
3. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415.
4. Xu D, Emoto N, Giaid A, et al. ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 1994; 78: 473-485.
5. Elshourbagy NA, Korman DR, Wu HL, et al. Molecular characterization and regulation of the human endothelin receptors. J Biol Chem 1993; 268: 3873-3879.
6. Battistini B, Chailler P, D'Orleans-Juste P, Briere N, Sirois P. Growth regulatory properties of endothelins. Peptides 1993; 14: 385-399.
7. Rockey DC, Chung JJ. Endothelin antagonism in experimental hepatic fibrosis: implications for endothelin in the pathogenesis of wound healing. J Clin Invest 1996; 98: 1381-1388.
8. Moore K, Wendon J, Frazer M, Karani J, Williams R, Badr K. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med 1992; 327: 1774-1778.
9. Alam I, Bass NM, Bacchetti P, Gee L, Rockey DC. Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites. Am J Gastroenterol 2000; 95: 199-203.
10. Gandhi CR, Sproat LA, Subbotin VM. Increased hepatic endothelin-1 levels and endothelin receptor density in cirrhotic rats. Life Sci 1996; 58: 55-62.
11. Pinzani M, Milani S, De Franco R, et al. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 1996; 110: 534-548.
12. Ohara N, Futagawa S, Watanabe S, Fukasawa M, Takamori S. Clinical investigation of endothelin-1 and nitric oxide in patients with portal hypertension focusing on plasma levels and immunohistological staining of liver tissues. Hepatol Res 2001; 21: 40-54.
13. Leivas A, Jimenez W, Bruix J, et al. Gene expression of endothelin-1 and ETA and ETB receptors in human cirrhosis: relationship with hepatic hemodynamics. J Vasc Res 1998; 35: 186-193.
14. Rothermund L, Cho JJ, Leggewie S, et al. Activation of the hepatic endothelin-system in rats with biliary liver fibrosis. J Cardiovasc Pharmacol 2000; 36: S270-S273.
15. Yokomori H, Oda M, Yasogawa Y, et al. Enhanced expression of endothelin B receptor at protein and gene levels in human cirrhotic liver. Am J Pathol 2001; 159: 1353-1362.
16. Reinehr RM, Kubitz R, Peters-Regehr T, Bode JG, Haussinger D. Activation of rat hepatic stellate cells in culture is associated with increased sensitivity to endothelin 1. Hepatology 1998; 28: 1566-1577.
17. Pilette C, Rousselet MC, Bedossa P, et al. Histopathological evaluation of liver fibrosis: quantitative image analysis vs semiquantitative scores. Comparison with serum markers. J Hepatol 1998; 28: 439-446.
18. Caballero T, Perez-Milena A, Masseroli M, et al. Liver fibrosis assessment with semiquantitative indexes and image analysis quantification in sustained-responder and non-responder interferon-treated patients with chronic hepatitis C. J Hepatol 2001; 34: 740-747.
19. Ogami M, Ikura Y, Ohsawa M, et al. Telomere shortening in human coronary artery diseases. Arterioscler Thromb Vasc Biol 2004; 24: 546-550.
20. Hirata Y, Yoshimi H, Takaichi S, Yanagisawa M, Masaki T. Binding and receptor down-regulation of a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. FEBS Lett 1988; 239: 13-17.
21. Eakes AT, Harvey SA, Olson MS. Endothelin association with cultured rat hepatic endothelial cells: functional characterization. Biochim Biophys Acta 1997; 1359: 153-164.
22. Shao R, Yan W, Rockey DC. Regulation of endothelin-1 synthesis by endothelin-converting enzyme-1 during wound healing. J Biol Chem 1999; 274: 3228-3234.
23. Shao R, Shi Z, Gotwals PJ, Koteliansky VE, George J, Rockey DC. Cell and molecular regulation of endothelin-1 production during hepatic wound healing. Mol Biol Cell 2003; 14: 2327-2341.
24. Hirata Y, Emori T, Eguchi S, et al. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest 1993; 91: 1367-1373.
25. Mallat A, Preaux AM, Serradeil-Le Gal C, et al. Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate-mediated pathway: inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin B receptors. J Clin Invest 1996; 98 2771-2778.
26. Cho JJ, Hocher B, Herbst H, et al. An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis. Gastroenterology 2000; 118: 1169-1178.